ArticleCancer research2014

The niacin/butyrate receptor GPR109A suppresses mammary tumorigenesis by inhibiting cell survival.

Selvakumar Elangovan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.